Navigation Links
Switch in cell's 'power plant' declines with age, rejuvenated by drug
Date:8/16/2011

Researchers at the Johns Hopkins University School of Medicine have found a protein normally involved in blood pressure regulation in a surprising place: tucked within the little "power plants" of cells, the mitochondria. The quantity of this protein appears to decrease with age, but treating older mice with the blood pressure medication losartan can increase protein numbers to youthful levels, decreasing both blood pressure and cellular energy usage. The researchers say these findings, published online during the week of August 15, 2011, in the Proceedings of the National Academy of Sciences, may lead to new treatments for mitochondrialspecific, age-related diseases, such as diabetes, hearing loss, frailty and Parkinson's disease.

"We've identified a functional and independently operated system that appears to influence energy regulation within the mitochondria," explains Jeremy Walston, M.D., professor of geriatric medicine at Hopkins. "This mitochondrial angiotensin system is activated by commonly utilized blood pressure medications, and influences both nitric oxide and energy production when signaled."

Previous research showed that manipulating angiotensin in the body's cells had unexpectedly affected mitochondrial energy production, so Walston and Peter Abadir , M.D., an assistant professor of geriatric medicine, decided to examine the role of angiotensin within the mitochondria. Using high-powered microscopy, they and their collaborators found evidence within the mitochondria of angiotensin as well as one of the protein receptors that bind to and detect it. They also pinpointed the angiotensin receptor's exact locations within the mitochondria of mouse kidney, liver, neuron and heart cells as well as in human white blood cells.

The team then treated mitochondria with a chemical known to activate the angiotensin receptors and measured the cell's response. This resulted in a decrease in oxygen consumption by half and a small increase in nitric oxide productionindicating less energy made by the mitochondria and lowered blood pressure, respectively. Explains Walston, "Activating angiotensin receptors within the mitochondria with these agents led to lowered blood pressure and decreased cellular energy use."

But they found even more than just an energy-regulating mechanism; after testing the angiotensin system in mitochondria of both young and old mice, they noticed a decrease by almost a third of the amount of the angiotensin receptor type 2 in the mitochondria in older mice, meaning that cells in older mice were unable to control energy use as well. The researchers then tried treating these older mice with the blood pressure lowering drug losartan daily for 20 weeks and found that the number of these receptors increased. "Treatment of the old mice with losartan resulted in a marked increase in the number of receptors that are known to positively influence blood pressure and decrease inflammation," says Walston.

Declining mitochondria are known to influence chronic diseases in older adults, explains Walston, whose next step is to translate studies from cell culture and animal based studies to human studies in hopes of developing new therapies. "Our findings will help us determine if the drugs that interact with this receptor will also lead to improvement of mitochondrial function and energy production. This, in turn, could facilitate the treatment of a number of chronic diseases of older adults."


'/>"/>

Contact: John Lazarou
jlazaro1@jhmi.edu
410-502-8902
Johns Hopkins Medical Institutions
Source:Eurekalert

Related medicine news :

1. Cochlear Appoints Switched on Media to Develop its SEO Across the Asia Pacific Region
2. Researchers create drug to keep tumor growth switched off
3. BCS Global Launches PSVN (Public Switched Video Network), an Initiative to Provide a Framework for Inter-Connecting Business to Business Video Networks
4. Daylight-Saving Time Switch May Leave You Sleepy, U-M Physician Says
5. Researchers discover brain tumors grow-or-go switch
6. Discovery of cellular switch may provide new means of triggering cell death, treating disease
7. UBC graduate student finds a start/stop switch for retroviruses
8. Brains master switch is verified by Iowa State University researcher
9. Clue to switch of bladder cancer from locally contained to invasive found by Jefferson scientists
10. Memorys master switch
11. Researchers create first molecule-blocks key component of cancer genes on-off switch
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... Intalere, the ... and suppliers for its inaugural Member Conference at the Paris Hotel in Las ... the operational health of America’s healthcare providers. , The conference was highlighted by ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... The ... Project offering a new model of care for living and healing, celebrated its ... values: Meaningful Life in a Real Home provided by Empowered Staff. , “This is ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... technologies and development solutions for drugs, biologics, consumer health and global clinical supply ... office in Korea to support the company’s continued investment and strategic growth plans ...
(Date:5/26/2016)... , ... May 26, 2016 , ... Memorial Day Weekend ... Amica Insurance is sharing tips to make sure your family and vehicle ... the National Safety Council, there may be 439 deaths and an additional 50,500 serious ...
(Date:5/26/2016)... ... May 26, 2016 , ... North Cypress Medical Center hosted ... Club in Cypress. With the help of community partners, the event organizers raised $45,000 ... hope for wounded service members and their families through health, wellness, and therapeutic support. ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... May 24, 2016   ... beide primären Endpunkte und demonstriert Ebenbürtigkeit ... ‚ausgezeichneter plus guter , ... ,      (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ... neue positive Daten von der MORA-Studie der Phase ...
(Date:5/24/2016)... May 24, 2016 Celsion Corporation (NASDAQ: ... company, today provided an update on its ongoing ... trial combining GEN-1, the Company,s DNA-based immunotherapy, with ... newly-diagnosed patients with advanced ovarian cancer who will ... GEN-1 is an IL-12 DNA plasmid vector formulated ...
(Date:5/24/2016)... , May 24, 2016 ... Education in Clinical Neurophysiology  Elsevier , ... products and services, today announced the launch of ... open access journal that focuses on clinical practice issues ... case reports, clinical series, normal values and didactic reviews. ...
Breaking Medicine Technology: